APA (7th ed.) Citation

Wang, S., Chao, J., Wang, H., Li, S., Wang, Y., Zhu, C., . . . Zhao, H. (2024). Effectiveness, safety, and biomarker analysis of lenvatinib plus toripalimab as chemo-free therapy in advanced intrahepatic cholangiocarcinoma. Cancer Immunology, Immunotherapy, 73(12), . https://doi.org/10.1007/s00262-024-03841-z

Chicago Style (17th ed.) Citation

Wang, Shanshan, et al. "Effectiveness, Safety, and Biomarker Analysis of Lenvatinib Plus Toripalimab as Chemo-free Therapy in Advanced Intrahepatic Cholangiocarcinoma." Cancer Immunology, Immunotherapy 73, no. 12 (2024). https://doi.org/10.1007/s00262-024-03841-z.

MLA (9th ed.) Citation

Wang, Shanshan, et al. "Effectiveness, Safety, and Biomarker Analysis of Lenvatinib Plus Toripalimab as Chemo-free Therapy in Advanced Intrahepatic Cholangiocarcinoma." Cancer Immunology, Immunotherapy, vol. 73, no. 12, 2024, https://doi.org/10.1007/s00262-024-03841-z.